Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon — Update
Haleon PLC HLN
News
Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon
Haleon Increases Stake in China JV to 88% for GBP500 Million
Haleon Lifts Profit Guidance on Profit Rise
Haleon to Sell Nicotine-Quitting Aid Business for $634 Million — Update
Haleon to Sell Nicotine-Quitting Aid Business for $634 Million
GSK Sells Last Haleon Shares for $1.58 Billion
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion — Update
GSK to Sell Stake in Haleon Valued at About $1.61 Billion
Haleon to Cut 435 Jobs, Shut U.K. Production Site
Haleon Taps Tate & Lyle Finance Chief Dawn Allen as CFO
Repeat & Correct: Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale — Update
Pfizer to Cut Stake in Haleon — Update
Pfizer to Cut Stake in Haleon to 24%
Haleon Backs Views After Profit Rise on Robust Growth — Update
Haleon Backs Views After Profit Rise on Robust Growth
Haleon Agrees to Sell ChapStick Brand for Up to $510 Million
Haleon Recalls Two Versions of Robitussin Due to Microbial Contamination
GSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted Placing
Indian Dr. Reddy's in Talks to Buy Haleon's Nicotinell, Sky News Reports
United States